%0 Journal Article
%T Resistance is futile: Targeting the inhibitory Fc¦ÃRIIB (CD32B) to maximize immunotherapy
%A Ali Roghanian
%A Bj£¿rn Frend¨¦us
%A Mark S. Cragg
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2015.1069939
%K CD32B
%K FcgRIIB
%K immunotherapy
%K mAb resistance
%K monoclonal antibody
%K therapyrituximab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801439/